2012 | |
---|---|
Criterium: | Position: |
Overall Score: | 600-700 |
Total Project Funding per Partner: | > 1000 |
Total Number of Projects: | 68 |
Total Project Funding: | > 1000 |
Networking Rank (Reputation): | 700-800 |
Networking Rank (Reputation): | 700-800 |
Partner Constancy: | 46 |
Project Leadership Index: | 73 |
Diversity Index: | 60 |
Total number of projects: 4
As coordinator: 1
As participant: 2
Sole participant: 1
Coordinator / Participant Ratio: 0.5*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2015 | 1.600.000 | 0 | 1.600.000 | 1 | ||
2012 | 1.303.000 | 9.149.786 | 637.109 | 1 | 2 |
Total number of partners: 34
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 34
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2015-07-01 | Scale-up of an Advanced Manufacturing process to produce a Pharmaceutical product Application (SAMPA). | SAMPA | coordinator | 1.600.000 | 1 |
2012-12-01 | Development of a hybrid process analytical technology to characterise the physical and chemical properties of particles | PARTICLE-PRO | participant | 1.149.786 | 9 |
2012-10-01 | Development of an oral Helicobacter Pylori vaccine | HELICOVAXOR | coordinator | 1.303.000 | 11 |
2012-05-01 | New Oral Nanomedicines: Transporting Therapeutic Macromolecules across the Intestinal Barrier | TRANS-INT | participant | 8.000.000 | 17 |